SPR Therapeutics, creator of a wearable neurostimulation device for chronic and acute pain management, announced that it had raised $37 million in a Series D
SPR Therapeutics, creator of a wearable neurostimulation device for chronic and acute pain management, announced that it had raised $37 million in a Series D